Biotechnology: Bio-E3 Policy, Sectoral Reforms & Biosafety
UPSC Mains PYQs
- Biotech Applications (2020): "What are the areas of application of biotechnology in the field of agriculture, medicine, and environment? How can biotechnology assist in raising the standard of living of people?" (15 Marks, 250 Words)
- Genetic Engineering Regulatory Framework (2021): Explain the role of the Genetic Engineering Appraisal Committee (GEAC) in the approval and commercial release of GM crops in India. Discuss the socioeconomic and ecological concerns associated with GM crops. (15 Marks, 250 Words)
📊 High-Yield Data & Statistical Fact Sheet
- Biotech & Bioeconomy Metrics:
- Bioeconomy Scale: Valued at $150+ Billion (~4% of India's GDP), with a policy target of $300 Billion by 2030.
- Global Footprint: India ranks 12th globally and 3rd in the Asia-Pacific region in biotechnology (~3% global share).
- Vaccine Hub: India accounts for 60% of the world's vaccine production.
- Startups (BIRAC): Sector expanded from 50 startups in 2012 to 6,750+ active biotech startups in 2026.
- Bio-E3 Focus: Target areas include bio-based chemicals, smart proteins, precision therapeutics, climate-resilient agri, carbon capture, and marine biotech.
India Bioeconomy Size (US$ Billion)
Loading chart...
1. THE BIO-E3 POLICY & INDIA'S BIOECONOMY
- Bio-E3 Policy Framework: (Biotechnology for Economy, Environment, and Employment). Approved to transition India from a fossil-resource economy to a high-yield circular bio-economy.
- Bio-manufacturing Hubs: Setting up specialized industrial parks for precision bio-therapeutics, cellular agriculture (smart proteins), carbon capture using algae, and functional bio-chemicals.
- GenomeIndia Project: Completed sequencing 10,000 reference genomes representing India's diverse population groups, establishing a database to accelerate precision medicine and diagnostic research.
2. SECTORAL APPLICATIONS: RED, GREEN & WHITE
- Red Biotech (Medicine):
- Precision Medicine: Tailoring drug regimes using Pharmacogenomics to maximize efficacy and prevent adverse reactions.
- Gene Therapy: Deploying CRISPR-Cas9 (e.g., BIRSA-101) to perform somatic gene editing to cure sickle cell anemia and thalassemia.
- Green Biotech (Agriculture): Engineering pest-resistant crops (Bt Cotton/Mustard) and using CRISPR scissors (TnpB molecular scissors) for target trait modification in rice and oilseeds.
- White Biotech (Industry & Environment): Using specialized nanozymes for blood-clotting diagnostics, and metabolic enzymes to synthesize bio-degradable bioplastics.
3. REGULATORY FRAMEWORK & ETHICAL SAFEGUARDS
- Genetic Engineering Appraisal Committee (GEAC): The apex statutory regulatory body under the Ministry of Environment, Forest and Climate Change (MoEFCC). Responsible for approving large-scale trials and commercial releases of genetically modified organisms (GMOs).
- BIRAC Nodal Role: Biotechnology Industry Research Assistance Council (a public sector enterprise of DBT) acts as a single-window interface to finance and mentor early-stage biotech startups.
- Biosafety & Biopiracy Moats: Enforcing strict compliance with the Cartagena Protocol on Biosafety to protect native biodiversity, and utilizing the People's Biodiversity Registers (PBR) to prevent biopiracy.
QUICK REVISION BOX
- Bioeconomy Target: $300 Billion by 2030.
- Bio-Manufacturing Policy: Bio-E3 Policy (DBT-led).
- Global Vaccine Share (India): 60%.
- Mains Biotech Startups Body: BIRAC.
- GM Crops Regulatory Apex: GEAC (under MoEFCC).
- Population Sequencing Database: GenomeIndia (10,000 genomes).
- Vernacular Biotech Incubator: BIRAC regional centers.
Notes updated up to March 2026. Sources: DBT Annual Reports, BIRAC Bioeconomy Assessments.